Glycoprotein IIB/IIIA inhibitors may modulate the clinical benefit of radial access as compared to femoral access in primary percutaneous coronary intervention: a meta-regression and a meta-analysis of randomized trials

Category Systematic review
JournalEUROPEAN HEART JOURNAL SUPPLEMENTS
Year 2021
This article has no abstract
Epistemonikos ID: 2782efa261b81d5dff415c29ea2834f08019d198
First added on: Feb 13, 2025